SIELC’s Alltesta™ Analyzer is an affordable HPLC analytical system that provides both scientific and educational environments with a convenient, simple solution for measuring small and trace concentrations of various chemicals in products such as milk, baby formula, pet food, pills, household formulations, and more.No difficult sample preparation is necessary, and no prior experience in chromatography or analytical chemistry is required for the operator. Measurements typically take less than 5 minutes, and the Alltesta™ comes with a set of supplies sufficient for 200 analyses.<ul><li>Small foot-print, light-weight, can be used on a small table</li><li>No difficult sample preparation</li><li>Takes only a few minutes to start operating</li><li>No chemical experience is required for instrument user</li><li>User friendly, self explanatory cloud-based software</li><li>Produces easy-to-understand results within 5-10 minutes</li></ul><h4>Alltesta Gradient Automated HPLC Analyzer includes:</h4><ul><li><a target="_blank" rel="noopener noreferrer" href="https://lcms.labrulez.com/products/1249">Alltesta™ Power Tower</a> (provides power and cloud connectivity)</li><li><a target="_blank" rel="noopener noreferrer" href="https://lcms.labrulez.com/products/1244">Alltesta Mini Autosampler</a> (includes <a target="_blank" rel="noopener noreferrer" href="https://lcms.labrulez.com/products/1245">Alltesta High-Pressure Switching Valve</a>)</li><li>Two <a target="_blank" rel="noopener noreferrer" href="https://lcms.labrulez.com/products/1247">Alltesta™ Ultra High Pressure Mini Syringe Pumps</a> for gradient flow</li><li><a target="_blank" rel="noopener noreferrer" href="https://lcms.labrulez.com/products/1248">Alltesta UV-Vis Detector</a></li></ul><img src="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/SIELC_Alltesta_automaticky_HPLC_gradientovy_analyzator_2_6aec49522f.jpg" alt="Bioanalytic / SIELC: Alltesta Gradient Automated HPLC Analyzer" srcset="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/thumbnail_SIELC_Alltesta_automaticky_HPLC_gradientovy_analyzator_2_6aec49522f.jpg 107w," sizes="100vw" width="1969" height="2881"><h3>Application examples using Alltesta HPLC</h3><h4><a target="_blank" rel="noopener noreferrer" href="https://lcms.labrulez.com/products/1242">Alltesta HPLC</a> Method for Berberine on <a target="_blank" rel="noopener noreferrer" href="https://lcms.labrulez.com/library?manufacturerItems=243&amp;search=Primesep+B">Primesep B</a> by SIELC Technologies</h4>Berberine is a naturally occurring alkaloid found in several plants, including the roots, rhizomes, and stem bark of plants such as Berberis species (barberry), Coptis chinensis (goldthread), and Hydrastis canadensis (goldenseal).<ul><li>Medicinal Properties: Berberine has been used in traditional medicine for its various medicinal properties, including antimicrobial, anti-inflammatory, and antioxidant effects.</li><li>Blood Sugar Regulation: Some studies suggest that berberine may help regulate blood sugar levels and improve insulin sensitivity, making it of interest in diabetes research.</li><li>Cholesterol Management: It has been investigated for potential benefits in managing cholesterol levels.</li><li>Anticancer Properties: Berberine has also shown promise in preclinical studies for its potential anticancer properties.</li></ul>Berberine supplements are available and marketed for various health purposes. In traditional medicine, berberine-containing plants have been used for treating various conditions.<h5>HPLC Method</h5><ul><li>Column: Primesep B, 3.2 x 150 mm, 5 µm, 100 A</li><li>Mobile Phase: MeCN/H2O – 20/80%</li><li>Buffer: H3PO4 -0.1%</li><li>Flow Rate:&nbsp;0.5 ml/min</li><li>Detection:&nbsp;UV 275 nm</li></ul><img src="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/Lab_Rulez_SIECL_Alltesta_HPLC_metoda_proanalyzu_Berberinu_na_kolone_Primesep_B_od_SIELC_Technologies_444d7c3d9c.jpg" alt="Bioanalytic / SIELC: Alltesta HPLC Method for Berberine on Primesep B by SIELC Technologies" srcset="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/thumbnail_Lab_Rulez_SIECL_Alltesta_HPLC_metoda_proanalyzu_Berberinu_na_kolone_Primesep_B_od_SIELC_Technologies_444d7c3d9c.jpg 241w," sizes="100vw" width="775" height="500"><h4><a target="_blank" rel="noopener noreferrer" href="https://lcms.labrulez.com/products/1242">Alltesta HPLC</a> Method for Prednisone, Methylprednisolone, Prednisolone on <a target="_blank" rel="noopener noreferrer" href="https://lcms.labrulez.com/library?manufacturerItems=243&amp;search=Primesep+B">Primesep B</a> by SIELC Technologies</h4>All three compounds have potent anti-inflammatory effects, making them valuable in treating conditions where inflammation plays a role.Prednisone:<ul><li>Mechanism of Action: Prednisone is a synthetic corticosteroid that mimics the action of cortisol, a natural steroid produced by the adrenal glands. It primarily exerts its effects by binding to glucocorticoid receptors and regulating gene expression.</li><li>Medical Uses: It is commonly used to treat inflammatory conditions, autoimmune disorders, allergic reactions, and certain cancers.</li></ul>Prednisolone:<ul><li>Derived Form: Prednisolone is the active form of prednisone. When prednisone is ingested, the liver converts it into prednisolone.</li><li>Mechanism of Action: Similar to prednisone, it has anti-inflammatory and immunosuppressive properties.</li></ul>Methylprednisolone:<ul><li>Potency: Methylprednisolone is considered to be more potent than prednisone.</li><li>Medical Uses: It is used in various conditions, including severe allergic reactions, inflammatory conditions, and as a part of immunosuppressive regimens.</li></ul>HPLC Method<ul><li>Column:&nbsp;Primesep B, 3.2 x 150 mm, 5 µm, 100 A</li><li>Mobile Phase: MeCN/H2O – 35/35%</li><li>Buffer: H3PO4 -0.1%</li><li>Flow Rate:&nbsp;0.5 ml/min</li><li>Detection: UV 275 nm</li></ul><img src="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/Lab_Rulez_SIELC_Alltesta_HPLC_metoda_pro_Prednison_Methylprednisolon_Prednisolon_na_kolone_Primesep_B_od_SIELC_Technologies_019e25f09c.jpg" alt="Bioanalytic / SIELC: Alltesta HPLC Method for Prednisone, Methylprednisolone, Prednisolone on Primesep B by SIELC Technologies" srcset="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/thumbnail_Lab_Rulez_SIELC_Alltesta_HPLC_metoda_pro_Prednison_Methylprednisolon_Prednisolon_na_kolone_Primesep_B_od_SIELC_Technologies_019e25f09c.jpg 224w," sizes="100vw" width="775" height="540"><h4>More examples of Alltesta™-based HPLC methods are available in the LabRulez Library</h4><ul><li><a target="_blank" rel="noopener noreferrer" href="https://lcms.labrulez.com/labrulez-bucket-strapi-h3hsga3/HPLC_Method_for_Analysis_of_Aspirin_in_Alka_Seltzer_Extra_Strength_Effervescent_Aspirin_on_Primesep_100_Column_d33816ae83.pdf">HPLC Method for Analysis of Aspirin in Alka-Seltzer Extra Strength Effervescent Aspirin</a></li><li><a target="_blank" rel="noopener noreferrer" href="https://lcms.labrulez.com/labrulez-bucket-strapi-h3hsga3/HPLC_Method_for_Analysis_of_Phenylephrine_Hydrochloride_1_in_Equate_Nasal_Spray_on_Primesep_100_Column_02f2983c25.pdf">HPLC Method for Analysis of Phenylephrine Hydrochloride 1% in Equate – Nasal Spray</a></li><li><a target="_blank" rel="noopener noreferrer" href="https://lcms.labrulez.com/labrulez-bucket-strapi-h3hsga3/HPLC_Method_for_Analysis_of_Rockstar_Zero_Carbs_Energy_Drink_with_Caffeine_and_Taurine_on_Primesep_100_Column_c87a85a0b4.pdf">HPLC Method for Analysis of Rockstar Zero Carbs Energy Drink with Caffeine and Taurine</a></li></ul>See this cloud-based example of the 2-Naphthalenesulfonic acid, Allura red, Fast Green FCF, 1,5-Naphthalenedisulfonic acid, Tartrazine separation method <a target="_blank" rel="noopener noreferrer" href="https://chrom.app/share/#/samples/11972/injection/21307/?t=a992fefcdd3647b19f6bed81e182d3d8">here</a>.<img src="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/SIELC_SIELC_Alltesta_Gradient_Automated_Analyzer_example_of_the_2_Naphthalenesulfonic_acid_Allura_red_Fast_Green_FCF_1_5_Naphthalenedisulfonic_acid_Tartrazine_separation_b96e648d63.jpg" alt="Bioanalytic / SIELC: SIELC Alltesta™ Gradient Automated Analyzer - example of the 2-Naphthalenesulfonic acid, Allura red, Fast Green FCF, 1,5-Naphthalenedisulfonic acid, Tartrazine separation" srcset="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/thumbnail_SIELC_SIELC_Alltesta_Gradient_Automated_Analyzer_example_of_the_2_Naphthalenesulfonic_acid_Allura_red_Fast_Green_FCF_1_5_Naphthalenedisulfonic_acid_Tartrazine_separation_b96e648d63.jpg 245w," sizes="100vw" width="1914" height="1134">

Compact, cost-effective HPLC system - SIELC Alltesta

<h4 style="text-align:justify;">Background</h4>TDM of immunosuppressants is extremely important topic, especially when it comes to sample collection at home coupled with simple and fast sample preparation and analysis. The aims of the study covered check if optimization of ready-to-use kit for determination of Tacrolimus (TAC), Sirolimus (SIR), Everolimus (EVR) and Cyclosporin A (CSA) in venous blood can be successfully applied for VAMS-collected blood and preliminary venous blood to Mitra® (VB/M) correlation study.<blockquote>Check the link for pdf of the original poster in the <a target="_blank" rel="noopener noreferrer" href="https://lcms.labrulez.com/labrulez-bucket-strapi-h3hsga3/Poster_Immuno_3000px_RGB_352b008e9d.pdf">LabRulezLCMS library</a>!</blockquote><h4 style="text-align:justify;">Methods</h4>Sample preparation for venous blood was done according to the procedure provided with the kit (Chromsystems kit: 93000). Sample preparation for Mitra®-collected blood included additional sonication, vortexing and combining of internal standards with extraction buffer. Only reagents supplied by the manufacturer were used. All samples were analyzed on <a target="_blank" rel="noopener noreferrer" href="https://lcms.labrulez.com/library?manufacturerItems=52&amp;search=QTRAP+5500%2B">QTRAP 5500+</a> LC-MS/MS system (SCIEX). Data processing, quantitation and basic statistical analysis was done in SciexOS 3.3 software (SCIEX).<img src="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/Bioanalytic_From_venous_blood_to_VAMS_adaptation_of_a_commercial_CE_IVD_assay_kit_for_the_determination_of_Tacrolimus_Sirolimus_Everolimus_and_Cyclosporin_A_Venous_Blood_Chromsystems_b496c1d87a.jpg" alt="Bioanalytic: Venous blood (Chromsystems procedure)" srcset="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/thumbnail_Bioanalytic_From_venous_blood_to_VAMS_adaptation_of_a_commercial_CE_IVD_assay_kit_for_the_determination_of_Tacrolimus_Sirolimus_Everolimus_and_Cyclosporin_A_Venous_Blood_Chromsystems_b496c1d87a.jpg 234w," sizes="100vw" width="1323" height="881"><img src="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/Bioanalytic_From_venous_blood_to_VAMS_adaptation_of_a_commercial_CE_IVD_assay_kit_for_the_determination_of_Tacrolimus_Sirolimus_Everolimus_and_Cyclosporin_A_Mitra_optimized_procedure_e671781241.jpg" alt="Bioanalytic: Mitra - optimized procedure based on Chromsystems kit." srcset="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/thumbnail_Bioanalytic_From_venous_blood_to_VAMS_adaptation_of_a_commercial_CE_IVD_assay_kit_for_the_determination_of_Tacrolimus_Sirolimus_Everolimus_and_Cyclosporin_A_Mitra_optimized_procedure_e671781241.jpg 211w," sizes="100vw" width="1340" height="994"><figure class="image"><img style="aspect-ratio:2064/674;" src="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/Bioanalytic_From_venous_blood_to_VAMS_adaptation_of_a_commercial_CE_IVD_assay_kit_for_the_determination_of_Tacrolimus_Sirolimus_Everolimus_and_Cyclosporin_A_Data_processing_quantitation_8529b80c50.jpg" alt="Bioanalytic: Data processing, quantitation and basic statistical analysis was done in SciexOS 3.3 software (SCIEX)." srcset="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/thumbnail_Bioanalytic_From_venous_blood_to_VAMS_adaptation_of_a_commercial_CE_IVD_assay_kit_for_the_determination_of_Tacrolimus_Sirolimus_Everolimus_and_Cyclosporin_A_Data_processing_quantitation_8529b80c50.jpg 245w," sizes="100vw" width="2064" height="674"></figure><h4 style="text-align:justify;">Results</h4>The optimized for 10µl and 20µl Mitra® samplers procedure met the validation criteria, including: reproducibility (%CV±15% and accuracy 85-115%), LLOQ (S/N≥10, calibrator 1), linearity (R≥0.995). LOD was not determined, however collected for 10 µl Mitra® sampler data shows that lower that 50 pg/ml concentration for each compound is achieved. The preliminary study of VB/M correlation, included 15 patients per compound where venous blood and 10 µl Mitra® samples were collected at the same time. Obtained VB/M factors were as follows: TAC=0.75, %CV=22.92%, SIR=0.77, %CV=36.10%, CSA=1.15, %CV=19.01%. No patients for EVR were tested during the study.<img src="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/Bioanalytic_From_venous_blood_to_VAMS_adaptation_of_a_commercial_CE_IVD_assay_kit_for_the_determination_of_Tacrolimus_Sirolimus_Everolimus_and_Cyclosporin_A_Tab_1_Validation_results_for_8c39ba1b30.jpg" alt="Bioanalytic: Tab. 1. Validation results for collected on 10 microL Mitra sampler lowest analytes concentrations provided with the kit (CAL 1, 4 replicates). LOD was not determined, however assitional analyses showed that lower that 50-100 pg/ml concentration for each compound can be achieved." srcset="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/thumbnail_Bioanalytic_From_venous_blood_to_VAMS_adaptation_of_a_commercial_CE_IVD_assay_kit_for_the_determination_of_Tacrolimus_Sirolimus_Everolimus_and_Cyclosporin_A_Tab_1_Validation_results_for_8c39ba1b30.jpg 245w," sizes="100vw" width="2679" height="925"><img src="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/Bioanalytic_From_venous_blood_to_VAMS_adaptation_of_a_commercial_CE_IVD_assay_kit_for_the_determination_of_Tacrolimus_Sirolimus_Everolimus_and_Cyclosporin_A_Tab_Results_of_preliminary_1d5b77648e.jpg" alt="Bioanalytic: Tab. 2. Results of preliminary study for VB/M correlation included 15 paptients par compound where venous blood and 10 microL Mitra samples were collected at the same time. No patients for EVR were tested during this study." srcset="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/thumbnail_Bioanalytic_From_venous_blood_to_VAMS_adaptation_of_a_commercial_CE_IVD_assay_kit_for_the_determination_of_Tacrolimus_Sirolimus_Everolimus_and_Cyclosporin_A_Tab_Results_of_preliminary_1d5b77648e.jpg 245w," sizes="100vw" width="2168" height="1117"><h4 style="text-align:justify;">Conclusions</h4>Optimized for VAMS procedure allowed to achieve validation criteria with the use of kit reagents. Additional steps required for Mitra® sample preparation are simple, robust and automation friendly. The VB/M correlations revealed that the capillary blood concentration of TAC and SIR are lower than in venous blood contrary to concentration of CSA. This data may support the fact that TAC and SIR enters erythrocytes in about 90%, while CSA only in 50% and the capillary blood has higher amount of serum fraction. However, due to relatively small number of patients included in the study it needs further investigation on larger group of patients and deeper statistical analysis.<blockquote><h4 style="text-align:justify;">Authors</h4>Rafał Szewczyk1,4; Arkadiusz Kocur2,3, Agnieszka Czajkowska3; Karina Izdebska4; Maciej Stopa1,4. 1LabExperts Sp. z o.o., Gdańsk, Poland; 2Department of Drug Chemistry, Pharmaceutical and Biomedical Analysis, Faculty of Pharmacy, Medical University of Warsaw, Warsaw, Poland; 3Therapeutic Drug Monitoring, Clinical Pharmacokinetics and Toxicology Laboratory Unit, Department of Clinical Biochemistry, The Children’s Memorial Health Institute, Warsaw, Poland; 4Bioanalytic Sp. z o.o., Gdańsk, Poland</blockquote>

From venous blood to VAMS – adaptation of a commercial CE-IVD assay kit for the determination of Tacrolimus, Sirolimus, Everolimus and Cyclosporin A

Article

Product

Events

Webinars

Application

Academy

Video

Poster

Scientists

Plastics

Environment

Food

Water

Health

Presentation

Scientific article

Interview

Toxicology

Popularization

Science and research

Software

Covid-19

Career

Laboratories

Various

Zaměření

Type of News

Focus

Bioanalytic started its operations in 1998. The company was born from a passion for science and the need to provide innovative solutions in the laboratory equipment market, from a small business to a dynamically developing company with an established position.

Bioanalytic

Analytical Strategies for Peptide & Protein Therapeutics

Advance Your SEC Knowledge Scientific Hands-on Workshop

36th MassSpec Forum Vienna 2026

LC Method Transfer: Hidden Challenges & Absolute Solution

From Complex to Simplicity: Get More Peace of Mind on Your HPLC Workflows with InfinityLab Assist

Food contaminant testing: Powerful workflow solutions for evolving residue analysis - from pesticides to PFAS